A detailed history of Beacon Capital Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Beacon Capital Management, LLC holds 237 shares of OGN stock, worth $4,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares
237
Previous 254 6.69%
Holding current value
$4,732
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$17.45 - $21.96 $296 - $373
-17 Reduced 6.69%
237 $4,000
Q1 2024

May 16, 2024

SELL
$13.78 - $18.8 $1,143 - $1,560
-83 Reduced 24.63%
254 $4,000
Q1 2023

Apr 20, 2023

SELL
$21.42 - $32.08 $1,349 - $2,021
-63 Reduced 15.75%
337 $7,000
Q4 2022

Jan 27, 2023

SELL
$23.31 - $28.61 $349 - $429
-15 Reduced 3.61%
400 $0
Q3 2022

Oct 05, 2022

SELL
$23.4 - $34.25 $93 - $137
-4 Reduced 0.95%
415 $15,000
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $12,758 - $16,491
419 New
419 $14,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.08B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Beacon Capital Management, LLC Portfolio

Follow Beacon Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Capital Management, LLC with notifications on news.